Le Lézard
Classified in: Science and technology
Subjects: Product/Service, Funding, Share Issue

GVE, a Developer of a Central Bank Digital Currency Platform Has Increased Its Valuation to 224 Billion Yen


GVE Ltd. (Headquarters: Tokyo, CEO: Koji Fusa, hereinafter "GVE") on 19th January 2022, resolved at a board of directors meeting to receive funds through a Series D financing. This financing is to provide funds for further development. The funds will be raised by the issue of shares to existing shareholders, including E-SET LLC (Headquarters: Saitama Prefecture, Representative Director: Madoka Kato, hereinafter "E-SET") at pre-money valuation of 224.2 billion yen.

GVE is a DX platform company with global ambitions, founded to develop and operate a digital fiat currency platform, or Central Bank Digital Currency. Two of the founders, Susumu Kusakabe and Koji Fusa have brought their combined experience and knowledge together to design a multi-Central Bank Digital Currency (CBDC) platform. This is likely to reduce the cost of cross border payments by 99%.

GVE has become the focus of interest globally for the high level of security which it offers against potential cyber attacks from quantum computers and reduces power consumption, through eliminating the more than 100,000 cash transport vehicles in operation worldwide. This has attracted the interest of future-oriented countries, which are seeking to achieve carbon neutrality as quickly as possible.

GVE's platform enables the banks to offer narrow banking within the existing legal framework and offer together with the fractional reserve banking. Furthermore, the superiority of GVE's technology compared to other companies is recognised because it complies with the ISO / IEC 24643 international standard. This ensures the interoperability with existing legacy systems at the same time as maintaining the security integrity of the entire financial system.
In addition to the CBDC platform, as the omicron virus continues to spread, GVE has developed a "vaccine passport," which allows original vaccine records and PCR or other test results to be accessed in real time, eliminating counterfeit records.

GVE:
Company name: GVE Ltd.
Residence: 13-1 Nihonbashi Kabutocho, Chuo-ku, Tokyo Kabutocho Kabuto Building Annex 4th floor
Representative Director: Koji Fusa
Homepage: https://gve.co.jp/en/


These press releases may also interest you

at 01:45
January - March 2024 Order intake increased +32 per cent (+29 organic), with strong growth in all three business areas. AirTech saw good demand, especially in the battery sub-segment in EMEA. Data Center Technologies (DCT) had a solid order intake in...

at 01:10
Envision Energy, a global leader in green technology, introduced its groundbreaking green hydrogen fuel solutions for the first time at Singapore Maritime Week, held from April 16 to April 19 in Singapore, exploring the new frontier of green fuel...

at 01:05
Investment funds managed by KKR, a leading global investment firm, have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care...

at 01:05
Regulatory News: BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, today announces an update on its business priorities. Going forward the Company...

at 01:05
On April 19, Ren Hongbin, Chairman of the China Council for the Promotion of International Trade (CCPIT) and the China Chamber of International Commerce (CCOIC), concluded a delegation's visit to New Zealand. The visit, highlighted by a session...

at 01:01
Allied Market Research published a report, titled, "Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers and Implantable Cardioverter Defibrillators, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Vagus...



News published on and distributed by: